Journal of Prosthetic Dentistry
Volume 88, Issue 3 , Pages 263-267 , September 2002

Susceptibility of Candida albicans isolates from the oral cavities of HIV-positive patients to histatin-5

References 

  1. Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida: clearance, colonization, or candidiasis?. J Dent Res. 1995;74:1152–1161
  2. Green SL. Anaerobic pleuro-pulmonary infections. Postgrad Med. 1979;65:62–66 68-9, 72-4
  3. Martin BJ, Corlew MM, Wood H, Olson D, Golopol LA, Wingo M, et al.  The association of swallowing dysfunction and aspiration pneumonia. Dysphagia. 1994;9:1–6
  4. Worthington M. Fetal candida pneumonia in a non-immunosuppressed host. J Infect. 1983;7:159–161
  5. Samaranayake LP. Host factors and oral candidosis. In:  Samaranayake LP,  MacFarlane TW editor. Oral candidosis. London: : Butterworth and Co Ltd; 1990;p. 66–103
  6. Helmerhorst EJ, Reijnders IM, van't Hof W, Simoons-Smit I, Veerman EC, Amerongen AV. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Chemother. 1999;43:702–704
  7. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev. 1998;11:382–402
  8. Barchiesi F, Hollis RJ, Del Poeta M, McGough DA, Scalise G, Rinaldi MG, et al.  Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis. Clin Infect Dis. 1995;21:561–564
  9. Situ H, Bobek LA. In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. Antimicrob Agents Chemother. 2000;44:1485–1493
  10. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, et al.  Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem. 1988;263:7472–7477
  11. Pollock JJ, Denepitiya L, MacKay BJ, Iacono VJ. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect Immun. 1984;44:702–707
  12. Murakami Y, Nagata H, Shizukuishi S, Nakashima K, Okawa T, Takigawa M, et al.  Histatin as a synergistic stimulator with epidermal growth factor of rabbit chondrocyte proliferation. Biochem Biophys Res Commun. 1994;198:274–280
  13. Edgerton M, Koshlukova SE, Lo TE, Chrzan BG, Straubinger RM, Raj PA. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J Biol Chem. 1998;273:20438–20447
  14. Nikawa H, Samaranayake LP, Tenovuo J, Pang KM, Hamada T. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei. Arch Oral Biol. 1993;38:1057–1063
  15. Nikawa H, Samaranayake LP, Tenovuo J, Hamada T. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin. Arch Oral Biol. 1994;39:921–923
  16. Nikawa H, Samaranayake LP, Hamada T. Modulation of the anti-Candida activity of apo-lactoferrin by dietary sucrose and tunicamycin in vitro. Arch Oral Biol. 1995;40:581–584
  17. Tobgi RS, Samaranayake LP, MacFarlane TW. The in vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol. 1987;3:35–39
  18. Nikawa H, Hayashi S, Nikawa Y, Hamada T, Samaranayake LP. Interactions between denture lining material, protein pellicles and Candida albicans. Arch Oral Biol. 1993;38:631–634
  19. Lal K, Santarpia RP, Xu L, Manssuri F, Pollock JJ. One-step purification of histidine-rich polypeptides form human parotid saliva and determination of anti-candidal activity. Oral Microbiol Immunol. 1992;7:44–50
  20. Tsai H, Bobek LA. Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans. Biochim Biophys Acta. 1997;1336:367–369
  21. Xu T, Levitz SM, Diamond RD, Oppenheim FG. Anticandidal activity of major human salivary histatins. Infect Immun. 1991;59:2549–2554
  22. Raj PA, Edgerton M, Levine MJ. Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity. J Biol Chem. 1990;265:3898–3905
  23. Mandel ID, Barr CE, Turgeon L. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med. 1992;21:209–213
  24. Sternberg S. The emerging fungal threat. Science. 1994;266:1632–1634
  25. Silverman S, Migliorati CA, Epstein JB, Samaranayake LP. Laboratory diagnosis of oral candidosis. In:  Samaranayake LP,  MacFarlane TW editor. Oral candidosis. London: : Butterworth and Co Ltd; 1990;p. 213–237
  26. Nikawa H, Hamada T. Binding of salivary or serum proteins to Candida albicans in vitro. Arch Oral Biol. 1990;35:571–573
  27. Nikawa H, Nishimura H, Yamamoto T, Hamada T, Samaranayake LP. The role of salivary or serum pellicle in the colonization process of Candida albicans on denture acrylic in vitro. Microbial Ecol Health Dis. 1996;9:35–48

☆ This study was supported by Grant-in-Aid 11470415.

☆☆ Reprint requests to: Dr Hiroki Nikawa, Department of Prosthetic Dentistry, Hiroshima University Faculty of Dentistry, 1-2-3 Kasumi Minami-ku, Hiroshima 734-8553, JAPAN, Fax: (81)82-257-5684, E-mail: hirocky@hiroshima-u.ac.jp

★ aLecturer, Department of Prosthetic Dentistry.

★★ bGraduate student, Department of Prosthetic Dentistry.

♢ clnstructor, Department of Prosthetic Dentistry.

♢♢ dProfessor and Chairman, Department of Prosthetic Dentistry.

♦ eProfessor, Oral Biology Unit, Hong Kong University.

PII: S0022-3913(02)00196-8

doi: 10.1067/mpr.2002.127907

Journal of Prosthetic Dentistry
Volume 88, Issue 3 , Pages 263-267 , September 2002

Article Tools

* Image Usage & Resolution